Wayne T. Markowitz's most recent trade in Edwards Lifesciences Corp was a trade of 26,400 Employee Stock Option (Right to Acquire) done . Disclosure was reported to the exchange on May 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 26,400 | 26,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 5,200 | 5,200 | - | - | Performance Rights | |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 5,200 | 22,762 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 79.73 per share. | 07 May 2026 | 593 | 21,679 (0%) | 0% | 79.7 | 47,280 | Common Stock |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.20 per share. | 07 May 2026 | 264 | 22,498 (0%) | 0% | 83.2 | 21,965 | Common Stock |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.76 per share. | 07 May 2026 | 226 | 22,272 (0%) | 0% | 82.8 | 18,704 | Common Stock |